OptimizeRx OPRX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's short-term investments?
- OptimizeRx (OPRX) reported short-term investments of $8.74M in Q1 2026.
- How has OptimizeRx's short-term investments changed year-over-year?
- OptimizeRx's short-term investments increased by 4.1% year-over-year, from $8.39M to $8.74M.
- What is the long-term trend for OptimizeRx's short-term investments?
- Over 2 years (2022 to 2025), OptimizeRx's short-term investments has grown at a -60.7% compound annual growth rate (CAGR), from $55.93M to $8.66M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.